blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0768882

EP0768882 - CARBAMAZEPINE MEDICAMENT WITH RETARDED ACTIVE SUBSTANCE RELEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.06.1999
Database last updated on 28.05.2024
Most recent event   Tooltip25.06.1999No opposition filed within time limitpublished on 11.08.1999 [1999/32]
Applicant(s)For all designated states
ARZNEIMITTELWERK DRESDEN GmbH
Postfach 01 01 31/01 01 32
D-01435 Radebeul / DE
[1997/17]
Inventor(s)01 / LANDGRAF, Karl-Friedrich
Heinrich-Greif-Strasse 37
01217 Dresden / DE
02 / REISS, Sabine
Lindenweg 15
01445 Radebeul / DE
03 / SCHUBERT, Eberhard
Karl-Liebknecht-Strasse 30
01445 Radebeul / DE
[1997/17]
Application number, filing date95922407.222.06.1995
[1997/17]
WO1995DE00805
Priority number, dateDE1994442307801.07.1994         Original published format: DE 4423078
[1997/17]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9601112
Date:18.01.1996
Language:DE
[1996/04]
Type: A1 Application with search report 
No.:EP0768882
Date:23.04.1997
Language:DE
The application published by WIPO in one of the EPO official languages on 18.01.1996 takes the place of the publication of the European patent application.
[1997/17]
Type: B1 Patent specification 
No.:EP0768882
Date:19.08.1998
Language:DE
[1998/34]
Search report(s)International search report - published on:EP18.01.1996
ClassificationIPC:A61K31/55, A61K9/28
[1997/17]
CPC:
A61K31/551 (EP,US); A61K31/55 (KR); A61K9/2081 (EP,US);
A61K9/28 (KR); A61K9/5026 (EP,US); A61P25/00 (EP);
A61P25/08 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/17]
Extension statesSI10.12.1996
TitleGerman:CARBAMAZEPIN-ARZNEIFORM MIT VERZÖGERTER WIRKSTOFFFREISETZUNG[1997/17]
English:CARBAMAZEPINE MEDICAMENT WITH RETARDED ACTIVE SUBSTANCE RELEASE[1997/17]
French:MEDICAMENT A LA CARBAMAZEPINE A LIBERATION RETARDEE DU PRINCIPE ACTIF[1997/17]
Entry into regional phase10.12.1996National basic fee paid 
10.12.1996Designation fee(s) paid 
10.12.1996Examination fee paid 
Examination procedure29.01.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
10.12.1996Examination requested  [1997/17]
29.12.1997Despatch of communication of intention to grant (Approval: Yes)
19.02.1998Communication of intention to grant the patent
11.03.1998Fee for grant paid
11.03.1998Fee for publishing/printing paid
Opposition(s)20.05.1999No opposition filed within time limit [1999/32]
Fees paidRenewal fee
18.06.1997Renewal fee patent year 03
10.06.1998Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]EP0080341  (BENZON AS ALFRED [DK]) [X] 1 * page 11, line 25 - page 13, line 11; claims 1,17,21,22,26 * [Y] 2-9;
 [XY]GB2122490  (ASTRA LAEKEMEDEL AB) [X] 1 * page 1, line 121 * * page 2, line 35 - line 79 * [Y] 2-9;
 [DA]DE3725824  (CIBA GEIGY AG [CH]) [DA] 1-9* page 3, line 39 - page 4, line 55 *;
 [XY]EP0388954  (FMC CORP [US]) [X] 1 * abstract * * page 4, line 17 - page 5, line 16 * [Y] 2-9
 [DA]  - Embase Abstract Nr. 93329228 & Pharm. Ind. 1993, Band 55, Nr. 10, S. 940-947 [DA] 1-9 * abstract *
 [A]  - P.GUINCHEDI ET AL., "Carbamazepine modified release dosage form", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, vol. 17, no. 13, pages 1753 - 1764 [A] 1-9 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.